Search research articles
Contact Us
Filters
Showing results (411-420 of 416) with videos related to
Page
of 42
Sort By:
You have reached the last page of results.
This site can display upto 416 results.
ACS Medicinal Chemistry Letters
|
June 20, 2014
Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL
Michael F T Koehler, Philippe Bergeron, Edna F Choo, et al.
Redox Biology
|
May 7, 2022
Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer
Muhammad Furqan, Taher Abu-Hejleh, Laura M Stephens, et al.
Proceedings. Biological Sciences
|
January 15, 2026
Habitat selection of three gull species in response to sudden changes in human mobility
Robert Patchett, Brian J Smith, Chris B Thaxter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2023
Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM
Michael S Petronek, Varun Monga, Kellie L Bodeker, et al.
Cancer Cell
|
April 4, 2017
O<sub>2</sub><sup>⋅-</sup> and H<sub>2</sub>O<sub>2</sub>-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
Joshua D Schoenfeld, Zita A Sibenaller, Kranti A Mapuskar, et al.
ACS Medicinal Chemistry Letters
|
October 15, 2014
Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
Zhi-Fu Tao, Lisa Hasvold, Le Wang, et al.
Page
of 42
Search research articles
Search
Showing results (411-420 of 416) with videos related to
Sort By:
Page
of 42
You have reached the last page of results.
This site can display upto 416 results.
ACS Medicinal Chemistry Letters
|
June 20, 2014
Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL
Michael F T Koehler, Philippe Bergeron, Edna F Choo, et al.
Redox Biology
|
May 7, 2022
Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer
Muhammad Furqan, Taher Abu-Hejleh, Laura M Stephens, et al.
Proceedings. Biological Sciences
|
January 15, 2026
Habitat selection of three gull species in response to sudden changes in human mobility
Robert Patchett, Brian J Smith, Chris B Thaxter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2023
Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM
Michael S Petronek, Varun Monga, Kellie L Bodeker, et al.
Cancer Cell
|
April 4, 2017
O<sub>2</sub><sup>⋅-</sup> and H<sub>2</sub>O<sub>2</sub>-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
Joshua D Schoenfeld, Zita A Sibenaller, Kranti A Mapuskar, et al.
ACS Medicinal Chemistry Letters
|
October 15, 2014
Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
Zhi-Fu Tao, Lisa Hasvold, Le Wang, et al.
Page
of 42